https://www.selleckchem.com/btk.html
02. The median overall survival (OS) was 17.3 months in the higher NLR group (≥3.02) and 27.3 months in the lower NLR group ( 3.02) (p 0.0001). This trend was also observed in both the ABI and ENZ groups (ABI 29.3 vs. 15.1 months; ENZ NR vs. 19.5 months; p 0.0001 and 0.0001, respectively). A multivariate analysis revealed that a higher NLR was an independent risk factor. The NLR value was thus shown to be correlated with the prostate cancer progression. A higher NLR was associated with a poorer OS for CRPC patients who received AB
Like
Comment
Share
